Keyphrases
United States
100%
Neutralizing Antibodies
100%
South Africa
100%
Serotype 5
100%
Adult Population
100%
Gambia
100%
Adenoviral
100%
Adenovirus
42%
Serum Samples
28%
Enhanced Green Fluorescent Protein (eGFP)
28%
Low Titer
28%
Adenoviral Gene Therapy
28%
Gene Therapy
14%
Mucosal Immune Response
14%
Fluorescence Microscopy
14%
Recombinant
14%
High Titer
14%
Systemic Immune Response
14%
South African
14%
High Prevalence
14%
Flow Cytometry
14%
Low Prevalence
14%
Lung Carcinoma Cells
14%
Adenovirus Type 5
14%
Virus Neutralization
14%
Gene Therapy Trials
14%
Antibody Prevalence
14%
Gene Therapy Vectors
14%
Gene Vaccine
14%
A549 Lung Carcinoma
14%
Immunocompetent Individual
14%
Immunology and Microbiology
Neutralizing Antibody
100%
Prevalence
100%
Serotype
100%
Adenoviridae
57%
Titer
28%
Mucosal Immune Response
14%
Neutralization
14%
Carcinoma Cell
14%
Antibody Titer
14%
Immunology
14%